triazolam has been researched along with Retinal Diseases in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Retinal Diseases: Diseases involving the RETINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thystrup, JD | 1 |
| Fledelius, HC | 1 |
| Miyagawa, M | 1 |
| Hayasaka, S | 1 |
| Noda, S | 1 |
2 other studies available for triazolam and Retinal Diseases
| Article | Year |
|---|---|
Retinal maculopathy possibly associated with amiodarone medication.
Topics: Amiodarone; Diltiazem; Female; Fundus Oculi; Humans; Laser Therapy; Middle Aged; Retina; Retinal Dis | 1994 |
Photic maculopathy resulting from the light of a video camera in patients taking triazolam.
Topics: Female; Humans; Light; Macula Lutea; Male; Middle Aged; Pupil; Radiation Injuries; Retinal Diseases; | 1994 |